Cara Therapeutics reported $0 in Debt for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Debt Change
Acadia Pharmaceuticals ACAD:US $ 0M 0M
Acelrx Pharmaceuticals ACRX:US $ 18.14M 1.91M
Aerie Pharmaceuticals AERI:US $ 222.02M 5.94M
Antares Pharma ATRS:US $ 26.15M 14.87M
Arena Pharmaceuticals ARNA:US $ 43.5M 1.09M
Cara Therapeutics CARA:US $ 0 0
Depomed DEPO:US $ 12.22M 71.95M
Endo International Ordinary Shares ENDP:US $ 8304.11M 3.58M
Halozyme Therapeutics HALO:US $ 874.74M 0.96M
Horizon Pharma HZNP:US $ 2576.44M 2.07M
JAZZ PHA JAZZ:US $ 6744.3M 4642.65M
Neurocrine Biosciences NBIX:US $ 326.3M 4.3M
Pacira Pharmaceuticals PCRX:US $ 475.39M 6.4M
Pain Therapeutics PTIE:US $ 0M 0M
Redhill Biopharma RDHL:US $ 87.83M 0.28M
Revance Therapeutics RVNC:US $ 280M 0.31M
Supernus Pharmaceuticals SUPN:US $ 370.38M 18.83M
Teva Pharmaceutical Industries TEVA:US $ 25132M 147M
Vanda Pharmaceuticals VNDA:US $ 0M 0M